Subcutaneous monoclonal antibody injection for eosinophil-targeted severe asthma control. Acquired by specialty pharmacies and infusion centers for biologic therapy protocols. Supplied by biotech firms via controlled distribution networks to rheumatologists and allergists in clinical settings.